Pulse Biosciences, Inc. Operating Expenses
Pulse Biosciences, Inc. (PLSE) reported Operating Expenses of $14.81 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-08-09
- Pulse Biosciences, Inc. operating expenses for the quarter ending 2021-06-30 was $14.81M, a 30.40% increase year-over-year.
- Pulse Biosciences, Inc. operating expenses for the quarter ending 2021-03-31 was $18.52M, a 55.02% increase year-over-year.
- Pulse Biosciences, Inc. operating expenses for the quarter ending 2020-12-31 was $13.76M, a 1.26% decline year-over-year.
- Pulse Biosciences, Inc. operating expenses for the quarter ending 2020-09-30 was $12.90M, a 7.87% increase year-over-year.
- Pulse Biosciences, Inc. operating expenses for fiscal 2020 was $49.97M, a 4.19% increase from fiscal 2019.
- Pulse Biosciences, Inc. operating expenses for fiscal 2019 was $47.95M, a 26.32% increase from fiscal 2018.
- Pulse Biosciences, Inc. operating expenses for fiscal 2018 was $37.96M, a 47.06% increase from fiscal 2017.
- Pulse Biosciences, Inc. operating expenses for fiscal 2017 was $25.81M, a 169.29% increase from fiscal 2016.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2021-06-30 | $14.81M 10-Q · filed 2021-08-09 | $33.33M 10-Q · filed 2021-08-09 | $47.09M derived: sum of 3 quarters · filed 2021-08-09 | $59.99M derived: sum of 4 quarters · filed 2021-08-09 | |
| 2021-03-31 | $18.52M 10-Q · filed 2021-05-10 | $32.28M derived: sum of 2 quarters · filed 2021-05-10 | $45.19M derived: sum of 3 quarters · filed 2021-05-10 | $56.54M derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-12-31 | $13.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $26.66M derived: sum of 2 quarters · filed 2021-03-12 | $38.02M derived: sum of 3 quarters · filed 2021-08-09 | $49.97M 10-K · filed 2021-03-12 | |
| 2020-09-30 | $12.90M 10-Q · filed 2020-11-09 | $24.26M derived: sum of 2 quarters · filed 2021-08-09 | $36.21M 10-Q · filed 2020-11-09 | $50.14M derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-06-30 | $11.35M 10-Q · filed 2021-08-09 | $23.30M 10-Q · filed 2021-08-09 | $37.23M derived: sum of 3 quarters · filed 2021-08-09 | $49.20M derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-03-31 | $11.95M 10-Q · filed 2021-05-10 | $25.88M derived: sum of 2 quarters · filed 2021-05-10 | $37.84M derived: sum of 3 quarters · filed 2021-05-10 | $49.49M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $13.93M 10-K · filed 2020-03-16 | $25.89M derived: sum of 2 quarters · filed 2020-11-09 | $37.54M derived: sum of 3 quarters · filed 2020-11-09 | $47.95M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $11.96M 10-Q · filed 2020-11-09 | $23.61M derived: sum of 2 quarters · filed 2020-11-09 | $34.02M 10-Q · filed 2020-11-09 | $43.08M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $11.65M 10-Q · filed 2020-08-10 | $22.06M 10-Q · filed 2020-08-10 | $31.12M derived: sum of 3 quarters · filed 2020-08-10 | $42.00M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $10.41M 10-Q · filed 2020-05-11 | $19.47M derived: sum of 2 quarters · filed 2020-05-11 | $30.35M derived: sum of 3 quarters · filed 2020-05-11 | $39.65M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $9.06M 10-K · filed 2020-03-16 | $19.94M derived: sum of 2 quarters · filed 2020-03-16 | $29.24M derived: sum of 3 quarters · filed 2020-03-16 | $37.96M 10-K · filed 2021-03-12 | |
| 2018-09-30 | $10.88M 10-K · filed 2020-03-16 | $20.18M derived: sum of 2 quarters · filed 2020-03-16 | $28.90M 10-Q · filed 2019-11-07 | $37.73M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $9.30M 10-K · filed 2020-03-16 | $18.02M 10-Q · filed 2019-08-08 | $26.86M derived: sum of 3 quarters · filed 2020-03-16 | $34.38M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | $8.72M 10-K · filed 2020-03-16 | $17.55M derived: sum of 2 quarters · filed 2020-03-16 | $25.08M derived: sum of 3 quarters · filed 2020-03-16 | $31.30M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2017-12-31 | $8.83M 10-K · filed 2019-03-14 | $16.36M derived: sum of 2 quarters · filed 2019-03-14 | $22.58M derived: sum of 3 quarters · filed 2019-03-14 | $25.81M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $7.53M 10-K · filed 2019-03-14 | $13.75M derived: sum of 2 quarters · filed 2019-03-14 | $16.98M 10-Q · filed 2018-11-01 | $19.83M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | $6.22M 10-K · filed 2019-03-14 | $9.46M 10-Q · filed 2018-07-31 | $12.30M derived: sum of 3 quarters · filed 2019-03-14 | $15.10M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-03-31 | $3.24M 10-K · filed 2019-03-14 | $6.08M derived: sum of 2 quarters · filed 2019-03-14 | $8.88M derived: sum of 3 quarters · filed 2019-03-14 | $11.14M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2016-12-31 | $2.84M 10-K · filed 2018-03-16 | $5.64M derived: sum of 2 quarters · filed 2018-03-16 | $7.90M derived: sum of 3 quarters · filed 2018-03-16 | $9.59M 10-K · filed 2019-03-14 | |
| 2016-09-30 | $2.80M 10-K · filed 2018-03-16 | $5.06M derived: sum of 2 quarters · filed 2018-03-16 | $6.74M 10-Q · filed 2017-11-08 | $8.28M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $2.26M 10-K · filed 2018-03-16 | $3.94M 10-Q · filed 2017-08-10 | $5.48M derived: sum of 3 quarters · filed 2018-03-16 | $6.71M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $1.68M 10-K · filed 2018-03-16 | $3.22M derived: sum of 2 quarters · filed 2018-03-16 | $4.45M derived: sum of 3 quarters · filed 2018-03-16 | $5.41M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $1.53M 10-K · filed 2017-03-20 | $2.77M derived: sum of 2 quarters · filed 2017-03-20 | $3.73M derived: sum of 3 quarters · filed 2017-03-20 | $4.47M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $1.23M 10-K · filed 2017-03-20 | $2.19M derived: sum of 2 quarters · filed 2017-03-20 | $2.93M 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $956.00K 10-K · filed 2017-03-20 | $1.70M 10-Q · filed 2016-08-10 | |||
| 2015-03-31 | $743.00K 10-K · filed 2017-03-20 | ||||
| 2014-12-31 | $300.00K 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |